Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain in heart patients
The approval by the US Food and Drug Administration (USFDA) is to manufacture and market Isosorbide Mononitrate Extended-Release, of strengths 30 mg, 60 mg, and 120 mg, Zydus Lifesciences said in a regulatory filing.
#Stock #Share #Market #News #Economy #Finance #News #Sensex #Nifty #Global #Market #NSE #BSE #Live #IPO #News